Lung Cancer
Roundtable
Treatment and Management of Patients With Non-Small Cell Lung Cancer
The following is a lightly edited manuscript of a teleconference discussion on treating patients with non -small cell lung cancer in the VHA.
News
EGFR-mutant NSCLC may still respond to PD-1 blockade
A woman presenting with EGFR-mutant non–small-cell lung cancer has shown high PD-L1 expression and responded well to PD-1 inhibitors.
Article
Depression Screening and Treatment: A Missed Opportunity in Lung Cancer Care
The integrated VA system is well positioned to be a leader in depression screening and treatment, and VA clinicians who care for patients with...
News
Rapid EGFR testing reduces time to therapy for patients with NSCLC
Rapid EGFR-specific testing in patients with NSCLC reduced median time to initiation (TTI) of therapy from 37 days to 22 days.
Article
Former Smokers Motivate Quitters
CDC campaign uses peer-to-peer influence to increase quit rates among smokers.
Original Research
Lung Cancer Screening: Translating Research Into Practice
According to the National Lung Screening Trial (NLST), use of low-dose computed tomography (LDCT) reduced lung cancer deaths by 20%. That finding...
Article
Clinical Puzzle: Lung Cancer or Hodgkin Lymphoma?
Making the right diagnosis when radiologic evidence is misleading.
Best Practices
Timeliness of Lung Cancer Diagnosis and Treatment
Most patients received timely histopathologic confirmation of diagnosis, but surgery candidates faced significant delays in care in this quality...
News
VA Partnership Expands Access to Lung Screening Programs
A partnership between the VA and the Bristol-Myers Squibb Foundation aims to increase access to lung cancer...
Case Reports
Complex Malignancies: A Diagnostic and Therapeutic Trilemma
A patient presented with esophageal adenocarcinoma, pulmonary small-cell carcinoma, and high-grade carcinoma, which is a rare occurrence that...